The board proposes Extraordinary General Meeting to get approval to conduct a rights issue of units
Aarhus, Denmark, February 6 2018 – Initiator Pharma A/S (”Initiator Pharma”), hereby announces that the board has proposed to an Extraordinary General Meeting to conduct a rights issue of up to 8 683 941 shares and 5 789 294 attached consideration-free share options of series TO1, as units. Fully subscribed rights issue provides Initiator Pharma initially with approximately SEK 19.1 million through subscription of shares and a further approximately SEK 12.7 million in the case that all attached share options are exercised. In total, approximately SEK 31.8 million before issuing costs. The